Amicus Therapeutics Stock (NASDAQ:FOLD)
Previous Close
$11.69
52W Range
$9.02 - $14.57
50D Avg
$10.75
200D Avg
$11.41
Market Cap
$3.46B
Avg Vol (3M)
$2.64M
Beta
0.69
Div Yield
-
FOLD Company Profile
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzyme replacement therapies for Pompe diseases; CLN3, which is in Phase 1/2 clinical study to evaluate the safety and efficacy of a single intrathecal administration of an AAV serotype AT-GTX-502 gene therapy in patients with CLN3; and CDKL5, a gene on the X-chromosome encoding the CDKL5 protein that regulates the expression of essential proteins for normal brain development. The company has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. Amicus Therapeutics, Inc. was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.
FOLD Performance
Peer Comparison
Ticker | Company |
---|---|
DICE | DICE Therapeutics, Inc. |
INCY | Incyte Corporation |
ARVN | Arvinas, Inc. |
DNLI | Denali Therapeutics Inc. |
DYN | Dyne Therapeutics, Inc. |
RVMD | Revolution Medicines, Inc. Warrant |
MREO | Mereo BioPharma Group plc |
BPMC | Blueprint Medicines Corporation |
MLYS | Mineralys Therapeutics, Inc. |
EWTX | Edgewise Therapeutics, Inc. |
DAWN | Day One Biopharmaceuticals, Inc. |
BMRN | BioMarin Pharmaceutical Inc. |
INBX | Inhibrx, Inc. |
LEGN | Legend Biotech Corporation |
CRNX | Crinetics Pharmaceuticals, Inc. |
HRMY | Harmony Biosciences Holdings, Inc. |
AGIO | Agios Pharmaceuticals, Inc. |
KURA | Kura Oncology, Inc. |
CYTK | Cytokinetics, Incorporated |
KRTX | Karuna Therapeutics, Inc. |
RARE | Ultragenyx Pharmaceutical Inc. |
ARGX | argenx SE |